Target intelligence / Profile preview

Natural antibacterials

Molecular classification
Other
01

Overview

Natural antibacterials are a diverse group of substances derived from plants, microbes (such as actinomycetes or fungi), animals, and sometimes minerals, which exhibit the capacity to inhibit or kill bacteria[3][5][7][8]. These compounds include a broad class of chemicals such as phenols, flavonoids, terpenes, alkaloids, peptides (like bacteriocins), and essential oils[3][5][7]. Their mechanisms of action include disruption of bacterial cell membranes, inhibition of key enzymes, and interference with protein or nucleic acid synthesis[1][3][7]. While some, like penicillin, have been developed into pharmaceuticals, many natural antibacterials are used in traditional medicine or as food preservatives. The group is too heterogeneous to define as a single drug target; rather, it comprises many unrelated molecules that act through independent mechanisms.\n\nBecause “Natural antibacterials” is not a specific molecular target but a compound category, this entry is **not suitable for single-target drug or mechanistic annotation** and should be flagged as incorrect in this context[1][3][8].

Other names
natural antibioticsnatural antimicrobial compoundsplant-derived antibacterialsnatural antimicrobial agents
02

Mechanism of action

Disruption of bacterial cell wall synthesis; Disruption of cell membranes; Inhibition of protein synthesis; Inhibition of nucleic acid synthesis; Inhibition/blockade of key bacterial metabolic pathways; Inhibition of bacterial biofilm formation; Immune modulation

03

Biological functions

Inhibition of bacterial growthanti-infectionimmune supportmicrobiome modulationOther
04

Disease associations

Infection (bacterial)Antimicrobial resistanceOther
05

Safety considerations

Variable toxicity (some natural antibacterials have higher toxicity than synthetic successors)Allergenicity (e.g., plant extracts, essential oils)Variation in potency and purityUnpredictable pharmacokineticsLimited clinical efficacy data for many agentsResistance development still possible
06

Interacting drugs

allicin

2 more in the full profile.

Beyond the preview

Go deeper on Natural antibacterials.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural antibacterials.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call